Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Nickolas Zaller to Substance Abuse, Intravenous

This is a "connection" page, showing publications Nickolas Zaller has written about Substance Abuse, Intravenous.

 
Connection Strength
 
 
 
5.706
 
  1. Ostrach B, Buer LM, Armbruster S, Brown H, Yochym G, Zaller N. COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains. J Rural Health. 2021 01; 37(1):252-255.
    View in: PubMed
    Score: 0.711
  2. Zaller N, Ostrach B. HCV, injection drug use, and the importance of harm reduction in Kenya. Lancet Infect Dis. 2019 11; 19(11):1158-1159.
    View in: PubMed
    Score: 0.670
  3. Zaller N, Mazhnaya A, Larney S, Islam Z, Shost A, Prokhorova T, Rybak N, Flanigan T. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care. Int J Drug Policy. 2015 Jan; 26(1):37-42.
    View in: PubMed
    Score: 0.474
  4. Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013 Jun; 48(8):590-9.
    View in: PubMed
    Score: 0.434
  5. Zaller ND, Yokell MA, Nayak SM, Fu JJ, Bazazi AR, Rich JD. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island. J Urban Health. 2012 Aug; 89(4):659-70.
    View in: PubMed
    Score: 0.409
  6. Zaller ND, Yokell MA, Apeakorang N, Gaggin J, Case P. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention. J Health Care Poor Underserved. 2012 Aug; 23(3):1310-26.
    View in: PubMed
    Score: 0.409
  7. Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J Addict Med. 2011 Sep; 5(3):175-80.
    View in: PubMed
    Score: 0.384
  8. Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. J Urban Health. 2010 Dec; 87(6):942-53.
    View in: PubMed
    Score: 0.364
  9. Zaller ND, Yokell MA, Jeronimo A, Bratberg JP, Case P, Rich JD. Adverse event associated with a change in nonprescription syringe sale policy. J Am Pharm Assoc (2003). 2010 Sep-Oct; 50(5):619-22.
    View in: PubMed
    Score: 0.358
  10. Zaller ND, Bazazi AR, Velazquez L, Rich JD. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health. 2009 02; 6(2):787-97.
    View in: PubMed
    Score: 0.322
  11. Zaller ND, Thurmond P, Brett J, Carleton JC, Rich JD. Linkage to methadone treatment from acute opiate detoxification treatment. J Opioid Manag. 2006 Nov-Dec; 2(6):341-6.
    View in: PubMed
    Score: 0.275
  12. Meteliuk A, Prokhorova T, Filippovych S, Ompad DC, Zaller N. The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data. Drug Alcohol Depend. 2020 11 01; 216:108216.
    View in: PubMed
    Score: 0.178
  13. Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013 Oct; 17 Suppl 2:S118-27.
    View in: PubMed
    Score: 0.111
  14. Nunn A, Zaller N, Dickman S, Nijhawan A, Rich JD. Improving access to opiate addiction treatment for prisoners. Addiction. 2010 Jul; 105(7):1312-3.
    View in: PubMed
    Score: 0.088
  15. Mitty JA, Bazerman LB, Selwyn K, Beckwith CG, Zaller ND, Rich JD. Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island. AIDS Read. 2008 Dec; 18(12):596-600.
    View in: PubMed
    Score: 0.079
  16. Beckwith CG, Zaller N, Flanigan TP. HIV counseling and testing among injection drug users needs to continue. Am J Public Health. 2007 Jul; 97(7):1161.
    View in: PubMed
    Score: 0.071
  17. Rich JD, Hogan JW, Wolf F, DeLong A, Zaller ND, Mehrotra M, Reinert S. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):292-7.
    View in: PubMed
    Score: 0.071
  18. Brim N, Zaller N, Taylor LE, Feller E. Twinrix vaccination schedules among injecting drug users. Expert Opin Biol Ther. 2007 Mar; 7(3):379-89.
    View in: PubMed
    Score: 0.070
  19. Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP. A success story: HIV prevention for injection drug users in Rhode Island. Subst Abuse Treat Prev Policy. 2006 Dec 04; 1:34.
    View in: PubMed
    Score: 0.069
  20. Zaller N, Nelson KE, Aladashvili M, Badridze N, del Rio C, Tsertsvadze T. Risk factors for hepatitis C virus infection among blood donors in Georgia. Eur J Epidemiol. 2004; 19(6):547-53.
    View in: PubMed
    Score: 0.056
  21. Brinkley-Rubinstein L, Crowley C, Montgomery MC, Peterson M, Zaller N, Martin R, Clarke J, Dubey M, Chan PA. Interest and Knowledge of HIV Pre-Exposure Prophylaxis in a Unified Jail and Prison Setting. J Correct Health Care. 2020 01; 26(1):36-41.
    View in: PubMed
    Score: 0.043
  22. Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.
    View in: PubMed
    Score: 0.037
  23. Wakeman SE, Zaller ND, Flanigan TP, Pinkston M, Montague BT, Rich JD. HIV among marginalized populations in Rhode Island. Med Health R I. 2009 Jul; 92(7):244-6.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.